1.19
0.85%
+0.01
Aclaris Therapeutics Inc (ACRS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
89.29%
17.57
|
9.282 | 1.869 | 2.528 | 7.753 |
Cost Of Revenue |
14.50%
0.725
|
0.848 | 1.042 | 0.808 | 0.877 |
Gross Profit |
99.73%
16.84
|
8.434 | 0.827 | 1.72 | 6.876 |
Operating Expenses
|
47.78%
20.89
|
40.01 | 32.64 | 31.64 | 35.95 |
Benefits Costs and Expenses |
52.45%
19.43
|
40.86 | 33.68 | 30.69 | 35.39 |
Costs And Expenses |
47.09%
21.62
|
40.86 | 33.68 | 32.45 | 36.83 |
Operating Income/Loss |
87.18%
-4.047
|
-31.58 | -31.82 | -29.92 | -29.08 |
Income/Loss From Continuing Operations Before Tax |
94.12%
-1.858
|
-31.58 | -29.57 | -28.16 | -27.64 |
Income Tax Expense/Benefit |
-0.367
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
94.90%
-1.491
|
-29.26 | -29.57 | -28.16 | -27.64 |
Net Income/Loss
|
94.90%
-1.491
|
-29.26 | -29.57 | -28.16 | -27.64 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.50%
0.3564
|
70.81 | 70.63 | 66.87 | 0.4959 |
Diluted Average Shares |
99.50%
0.3564
|
70.81 | 70.63 | 66.87 | 0.4959 |
Basic Earnings Per Share |
95.12%
-0.02
|
-0.41 | -0.42 | -0.42 | -0.41 |
Diluted Earnings Per Share |
95.12%
-0.02
|
-0.41 | -0.42 | -0.42 | -0.41 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):